Mainz Biomed B.V.
NASDAQ:MYNZ
0.2541 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 7.071 | 17.142 | 8.728 | 0.123 | 0.204 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 7.071 | 17.142 | 8.728 | 0.123 | 0.204 |
| Net Receivables
| 0.355 | 0.259 | 0.112 | 0.044 | 0.041 |
| Inventory
| 0.614 | 0.175 | -863.14 | 0 | 0 |
| Other Current Assets
| 0.941 | 801.959 | 863.91 | 0.02 | 0.016 |
| Total Current Assets
| 8.98 | 18.378 | 9.609 | 0.186 | 0.26 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 3.034 | 1.839 | 0.432 | 0.487 | 0.456 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 3.395 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 3.395 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 0.023 | -0.432 | -0.487 | 0 |
| Total Non-Current Assets
| 6.429 | 1.863 | 0.432 | 0.487 | 0.456 |
| Total Assets
| 15.409 | 20.241 | 10.041 | 0.673 | 0.716 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 2.359 | 1.333 | 0.833 | 0.249 | 0.2 |
| Short Term Debt
| 5.225 | 1.326 | 0.249 | 0.267 | 0.207 |
| Tax Payables
| 0 | 0 | 0.003 | 0.02 | 0.005 |
| Deferred Revenue
| 0.139 | 0.199 | 0 | 0.002 | 0.003 |
| Other Current Liabilities
| 1.514 | 1.384 | 0.271 | 0.185 | 0.05 |
| Total Current Liabilities
| 9.237 | 4.243 | 1.352 | 0.702 | 0.46 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 2.196 | 1.902 | 2.328 | 2.713 | 2.207 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.727 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 2.923 | 1.902 | 2.328 | 2.713 | 2.207 |
| Total Liabilities
| 12.16 | 6.145 | 3.68 | 3.415 | 2.666 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.236 | 0.165 | 0.141 | 0.106 | 0.106 |
| Retained Earnings
| -69.328 | -43.032 | -16.645 | -4.955 | -4.368 |
| Accumulated Other Comprehensive Income/Loss
| 20.834 | 18.132 | 9.739 | 2.107 | 2.312 |
| Other Total Stockholders Equity
| 51.508 | 38.832 | 13.126 | 0 | 0 |
| Total Shareholders Equity
| 3.249 | 14.096 | 6.361 | -2.742 | -1.95 |
| Total Equity
| 3.249 | 14.096 | 6.361 | -2.742 | -1.95 |
| Total Liabilities & Shareholders Equity
| 15.409 | 20.241 | 10.041 | 0.673 | 0.716 |